The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Related Posts
LTM to Account for the Largest Implementations as L&T Drives an AI Powered Workplace Transformation With Microsoft 365 Copilot
Business Wire India LTM, a Larsen & Toubro Group company and the Business Creativity partner to the world’s largest enterprises,…
Ivy Growth Associates announces second season of Start-up Summit <21BY72>, 200+ Start-ups and 500+ Investors expected to join in Surat
08th June 2023, SURAT, India: IVY Growth Associates, a venture capital firm and start-up accelerator, in partnership with SteamHouse India…
Nesco Events Successfully Organizes Asia’s Largest World of Education Expo
Mumbai, 22 February 2023: Nesco Events successfully organized Asia’s largest World of Education Expo in Mumbai on February 17-19th. This…